Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Boston Scientific Corp (BSX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 48,542,356
  • Shares Outstanding, K 1,390,500
  • Annual Sales, $ 9,823 M
  • Annual Income, $ 1,671 M
  • 60-Month Beta 0.87
  • Price/Sales 5.12
  • Price/Cash Flow 16.75
  • Price/Book 5.74

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate 0.36
  • Number of Estimates 11
  • High Estimate 0.36
  • Low Estimate 0.35
  • Prior Year 0.33
  • Growth Rate Est. (year over year) +9.09%

Price Performance

See More
Period Period Low Period High Performance
1-Month
34.35 +2.21%
on 04/18/19
39.00 -9.97%
on 04/01/19
-2.86 (-7.53%)
since 03/18/19
3-Month
34.35 +2.21%
on 04/18/19
41.00 -14.37%
on 03/04/19
-2.58 (-6.85%)
since 01/18/19
52-Week
27.91 +25.80%
on 04/25/18
41.00 -14.37%
on 03/04/19
+6.17 (+21.32%)
since 04/18/18

Most Recent Stories

More News
Can Boston Scientific's (BSX) Steady Growth Aid Q1 Earnings?

We are optimistic about Boston Scientific's (BSX) IC business that will help maintain its impressive global growth trend in Q1 owing to an innovative portfolio and strong commercial teams.

CERN : 62.71 (+0.50%)
BSX : 35.11 (+0.57%)
TMO : 259.78 (+0.88%)
GWPH : 155.87 (+0.08%)
Global Neuromodulation Markets 2019-2024 Featuring Major Players - Medtronic, Boston Scientific, St. Jude Medical, Synapse Biomedical, and Nevro

The "Neuromodulation Market - Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering.

BSX : 35.11 (+0.57%)
STJ : 80.82 (+0.16%)
MDT : 84.22 (-0.60%)
Option-trading opportunities on Boston Scientific Corp., DowDuPont Inc., HP Inc., Marvell Technology, and Netflix Inc.

InvestorsObserver issues critical PriceWatch Alerts for BSX, DWDP, HPQ, MRVL, and NFLX.

NFLX : 360.35 (+1.58%)
BSX : 35.11 (+0.57%)
HPQ : 20.52 (+0.10%)
DWDP : 39.00 (-0.51%)
MRVL : 24.85 (-0.08%)
After Yesterday's Decline of 3.09%, Boston Scientifc Offers Investors Better Value

Boston Scientifc (NYSE:BSX) traded in a range yesterday that spanned from a low of $36.64 to a high of $38.09. Yesterday, the shares fell 3.1%, which took the trading range below the 3-day low of $37.56...

BSX : 35.11 (+0.57%)
Watch for Boston Scientifc to Potentially Rebound After Falling 3.09% Yesterday

Boston Scientifc (NYSE:BSX) traded in a range yesterday that spanned from a low of $36.64 to a high of $38.09. Yesterday, the shares fell 3.1%, which took the trading range below the 3-day low of $37.56...

BSX : 35.11 (+0.57%)
Biotech Brief: Clinical Progress Leading to New Technological Developments for Arrhythmia Monitoring

A recent market research report from a well-respected industry source, Grand View Research, said that it expects the Arrhythmia Monitoring Devices Market to be worth $8.41 billion by 2025 with a CAGR of...

ABT : 73.92 (+1.43%)
BSX : 35.11 (+0.57%)
JNJ : 137.52 (-0.72%)
BSGM : 6.35 (+1.28%)
BPTH : 19.02 (-5.93%)
The Americas GERD & NERD treatment market is anticipated to grow at the CAGR of 4.02% during the forecast period 2017-2023

Gerd & Nerd Treatment Market Information, By Drug Class (Antacids (Acid Neutralizers), Proton Pump Inhibitors, H2 Receptor Blocker), Dosage Form (Solid and Liquid), End User (Hospitals & Clinics, Research...

VRX.TO : 30.80 (-3.33%)
STIM : 15.56 (-0.06%)
IRWD : 11.24 (+0.99%)
AZN : 38.80 (+0.08%)
BSX : 35.11 (+0.57%)
MDGS : 2.80 (-5.08%)
CEMP : 2.33 (+1.30%)
MDT : 84.22 (-0.60%)
ESALF : 55.0000 (-4.93%)
GSK : 39.85 (-0.33%)
Transcatheter Aortic Valve Replacement Market (TAVR) Key Players Analysis- Edwards Lifesciences, Medtronic, Boston Scientific, St. Jude Medical, Direct Flow Medical and Meril Life Sciences

ReportsnReports added Transcatheter Aortic Valve Replacement (TAVR) Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Transcatheter...

EW : 177.26 (-0.13%)
BSX : 35.11 (+0.57%)
STJ : 80.82 (+0.16%)
MDT : 84.22 (-0.60%)
Can Boston Scientific (BSX) Keep the Earnings Surprise Streak Alive?

Boston Scientific (BSX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

BSX : 35.11 (+0.57%)
United States Hemostasis Devices Market Report 2019-2025 Featuring Boston Scientific, Cook Medical, Olympus, ERBE, CONMED, US Endoscopy & Telemed Systems - ResearchAndMarkets.com

The "Hemostasis Devices Market Report - United States - 2019-2025" report has been added to ResearchAndMarkets.com's offering.

BSX : 35.11 (+0.57%)
CNMD : 79.42 (+1.47%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators mostly agree with the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade BSX with:

Business Summary

Boston Scientific Corporation transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader they advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce...

See More

Key Turning Points

2nd Resistance Point 36.16
1st Resistance Point 35.64
Last Price 35.11
1st Support Level 34.47
2nd Support Level 33.82

See More

52-Week High 41.00
Fibonacci 61.8% 36.00
Last Price 35.11
Fibonacci 50% 34.46
Fibonacci 38.2% 32.91
52-Week Low 27.91

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar